Microphysiological systems to study tumor-stroma interactions in brain cancer

Area of Science:

• Neuro-oncology
• Biomedical Engineering
• Drug Discovery

Background:

• Brain tumors lack effective treatments, with unclear progression and resistance mechanisms.
• Current preclinical models (cell lines, animal models) fail to accurately mimic human disease, leading to high drug trial failure rates.
• Understanding tumor-stroma interactions is crucial for developing effective brain tumor therapies.

Purpose of the Study:

• To review advancements in microphysiological brain tumor models, specifically tumor-on-a-chip platforms.
• To highlight the role of these models in understanding the brain tumor microenvironment and stromal cell interactions.
• To assess the potential of these platforms in improving preclinical drug screening and predicting patient response.

Main Methods:

• Review of current literature on microphysiological systems and tumor-on-a-chip technologies for brain tumors.
• Focus on platforms incorporating key components of the brain tumor microenvironment, such as vascularization and stromal cells (astrocytes, microglia).
• Analysis of how these models enhance physiological relevance compared to traditional methods.

Main Results:

• Microphysiological brain tumor models create "minitumors" that are physiologically relevant and vascularized.
• These platforms facilitate the study of complex tumor-stroma interactions within the brain tumor microenvironment.
• Tumor-on-a-chip systems show potential for increased throughput and predictive capability in preclinical research.

Conclusions:

• Microphysiological brain tumor models represent a significant technological advance for studying brain tumors in vitro.
• These models offer a more accurate preclinical system for deciphering disease mechanisms and accelerating drug discovery.
• Tumor-on-a-chip platforms hold promise for predicting patient response to anticancer treatments and improving therapeutic strategies.